Zhi-yong Luo
Xiangya Stomatological Hospital And Xiangya School Of Stomatology/Hunan Key Laboratory Of Oral Health Research
Changsha, 410008, China
Changsha, 410008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Therapeutic efficacy of ASS1 combined with LOLA in the treatment of hyperammonemia in mice
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: April 25, 2026
Silybin Derivative B1 Inhibits Myofibroblast Activation via Wnt/DAAM2 and Ameliorates Oral Submucous Fibrosis in Mice.
Journal: International dental journal
Published: March 25, 2026
Design, Synthesis, and Evaluation of Novel Oxime-Ether Derivatives of Spinosyn A as ASS1 Activators and Antitumor Agents.
Journal: Journal of medicinal chemistry
Published: February 12, 2026
Spinosyn A derivatives as ASS1 activators and tumor inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: October 30, 2025
Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway.
Journal: Journal of natural products
Published: September 08, 2023
ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis.
Journal: Cell death & disease
Published: August 02, 2023
ZLM-7 Blocks Breast Cancer Progression by Inhibiting MDM2 via Upregulation of 14-3-3 Sigma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 09, 2022
Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα pathway.
Journal: Acta biochimica et biophysica Sinica
Published: May 20, 2022
Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues.
Journal: Bioorganic & medicinal chemistry letters
Published: March 26, 2020
ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 04, 2020
Last Updated: 09/26/2026